ID   MOLT-14
AC   CVCL_1423
SY   Molt-14; MOLT 14; Molt 14; MOLT14; Molt14
DR   BTO; BTO:0004172
DR   CLO; CLO_0007821
DR   BioSample; SAMN03473544
DR   cancercelllines; CVCL_1423
DR   Cell_Model_Passport; SIDM00432
DR   Cosmic; 998729
DR   Cosmic; 1037682
DR   Cosmic; 1281379
DR   Cosmic; 1330490
DR   Cosmic; 2602926
DR   DSMZ; ACC-437
DR   DSMZCellDive; ACC-437
DR   GEO; GSM5137761
DR   LINCS_LDP; LCL-2061
DR   PRIDE; PXD023662
DR   Wikidata; Q54906345
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2784121;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=35354797;
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-437).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Deep quantitative proteome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-437
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12,13
ST   D16S539: 9,11
ST   D18S51: 17,18
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 10,13
ST   FGA: 19,22,23
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8151 ! MOLT-12
OI   CVCL_1422 ! MOLT-13
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 24
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=2784121; DOI=10.1002/hon.2900070203;
RA   Drexler H.G., Minowada J.;
RT   "Morphological, immunophenotypical and isoenzymatic profiles of human
RT   leukemia cells and derived T-cell lines.";
RL   Hematol. Oncol. 7:115-125(1989).
//
RX   PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4;
RA   Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.;
RT   "Frequent microsatellite instability and BAX mutations in T cell acute
RT   lymphoblastic leukemia cell lines.";
RL   Leuk. Res. 24:255-262(2000).
//
RX   PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1;
RA   Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.;
RT   "Corrigendum to: Frequent microsatellite instability and BAX mutations
RT   in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24
RT   (2000),255-262.";
RL   Leuk. Res. 25:275-278(2001).
//
RX   PubMed=35354797; DOI=10.1038/s41467-022-29224-5;
RA   Leo I.R., Aswad L., Stahl M., Kunold E., Post F., Erkers T.,
RA   Struyf N., Mermelekas G., Joshi R.N., Gracia-Villacampa E.,
RA   Ostling P., Kallioniemi O.-P., Pokrovskaja Tamm K., Siavelis I.,
RA   Lehtio J., Vesterlund M., Jafari R.;
RT   "Integrative multi-omics and drug response profiling of childhood
RT   acute lymphoblastic leukemia cell lines.";
RL   Nat. Commun. 13:1691.1-1691.19(2022).
//